Voleon Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$965K Sell
3,297
-27,882
-89% -$9.16M 0.02% 447
2025
Q4
$10.9M Sell
31,179
-17,196
-36% -$5.81M 0.24% 86
2025
Q3
$15.6M Buy
48,375
+34,026
+237% +$10.6M 0.38% 47
2025
Q2
$5.58M Buy
+14,349
New +$5.77M 0.31% 81
2025
Q1
Sell
-7,233
Closed -$2.67M 359
2024
Q4
$2.67M Buy
+7,233
New +$3.03M 0.2% 116
2019
Q4
Sell
-54,000
Closed -$13M 207
2019
Q3
$13M Buy
+54,000
New +$14.8M 1% 24

Other funds holding ELV

Voleon Capital Management's ELV Position: Q1 2026 in Review

Voleon Capital Management reduced its Elevance Health (ELV) stake by 89% in Q1 2026, selling an estimated $9.16M and leaving 3,297 shares worth $965K. The position accounts for 0.02% of the portfolio, ranked #447.

Voleon Capital Management first reported a position in ELV in Q3 2019 and has held it in 6 quarters since. The position peaked at $15.6M in Q3 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Voleon Capital Management held 3,297 shares of Elevance Health worth $965K as of Q1 2026.
  • Voleon Capital Management sold 27,882 Elevance Health shares in Q1 2026, an estimated $9.16M.
  • Elevance Health made up 0.02% of Voleon Capital Management's portfolio in Q1 2026, its #447 holding.
  • Voleon Capital Management first reported a position in Elevance Health in Q3 2019 and has held it in 6 quarters since.
  • Voleon Capital Management's Elevance Health position peaked at $15.6M in Q3 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.